Sjogren's Disease Clinical Trials

16 clinical trials for Sjogren's Disease across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune Diseases — RECRUITING · PHASE1
• Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden — RECRUITING · PHASE3
• Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia — RECRUITING · PHASE1
• A Randomized, Placebo-controlled, Double-blind, Multicenter Phase 3 Protocol to Assess the Efficacy and Safety of Nipocalimab in Adults with Moderate to Severe Sjögren's Disease (SjD) — RECRUITING · PHASE3
• A Phase 1b, Open-Label Study of CLN-978 for the Treatment of Active, Moderate to Severe Sjogren’s Disease — RECRUITING · PHASE1
• Explanatory Factors and Predictors of Fatigue in Patients With Sjögren's Disease: A 3-month Longitudinal Study — RECRUITING
• A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease — NOT_YET_RECRUITING · PHASE2
• A Study of ATG-201 in Adult Participants With Autoimmune Diseases — NOT_YET_RECRUITING · PHASE1
• A Trial in Healthy Adult Participants and Adults With Autoimmune Disease to Test How HBM7020 is Tolerated and Absorbed in the Body — NOT_YET_RECRUITING · PHASE1
• Tolerance and Efficacy of Rituximab in Sjogren's Disease — COMPLETED · PHASE2
• A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of Abiprubart in Participants with Sjögren’s Disease — OTHER · PHASE2
• ANISE-II; ANIfrolumab treatment for 24 weeks in patients with primary Sjögren’s syndrome – Efficacy and safety assessment in a randomized, double-blind, placebo-controlled phase-IIa proof-of-concept trial — OTHER · PHASE2
• Multi-Colored Placido Disk Viability — COMPLETED · NA
• Evaluation of the Reproducibility Inter-observer of the Ultrasound Anomalies of the Salivary Glands in Sjogren's Disease — COMPLETED · NA
• Evaluation of Ocular Surface Inflammatory Mediators Effected by Lotemax — COMPLETED · NA
• Cord Blood Serum in the Treatment of Ocular Surface Diseases — COMPLETED

Refine this search